These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27638348)

  • 1. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
    Sardi JC; Gullo FP; Freires IA; Pitangui NS; Segalla MP; Fusco-Almeida AM; Rosalen PL; Regasini LO; Mendes-Giannini MJ
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):387-391. PubMed ID: 27638348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
    Sun L; Liao K; Hang C
    Phytomedicine; 2018 Feb; 40():55-58. PubMed ID: 29496175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
    Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
    Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal activity of the berberine and its synergism with fluconazole.
    Iwazaki RS; Endo EH; Ueda-Nakamura T; Nakamura CV; Garcia LB; Filho BP
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):201-5. PubMed ID: 19882381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
    Chopde N; Pharande A; Khade MN; Khadtare YR; Shah SS; Apratim A
    J Contemp Dent Pract; 2012 Sep; 13(5):695-8. PubMed ID: 23250177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activity of cinnamic acid and benzoic acid esters against Candida albicans strains.
    Lima TC; Ferreira AR; Silva DF; Lima EO; de Sousa DP
    Nat Prod Res; 2018 Mar; 32(5):572-575. PubMed ID: 28423912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
    da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA
    Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
    de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
    BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of caffeic acid derivatives against Candida albicans biofilm.
    De Vita D; Friggeri L; D'Auria FD; Pandolfi F; Piccoli F; Panella S; Palamara AT; Simonetti G; Scipione L; Di Santo R; Costi R; Tortorella S
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1502-5. PubMed ID: 24582984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
    Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
    Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
    Guo N; Wu X; Yu L; Liu J; Meng R; Jin J; Lu H; Wang X; Yan S; Deng X
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
    Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
    Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells.
    Braga PC; Maci S; Dal Sasso M; Bohn M
    Chemotherapy; 1996; 42(4):259-65. PubMed ID: 8804793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
    Messier C; Grenier D
    Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole.
    Huang S; Cao YY; Dai BD; Sun XR; Zhu ZY; Cao YB; Wang Y; Gao PH; Jiang YY
    Biol Pharm Bull; 2008 Dec; 31(12):2234-6. PubMed ID: 19043205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy of Clinically Approved Antifungal Drugs Is Enhanced by Conjugation with Silver Nanoparticles.
    Hussain MA; Ahmed D; Anwar A; Perveen S; Ahmed S; Anis I; Shah MR; Khan NA
    Int Microbiol; 2019 Jun; 22(2):239-246. PubMed ID: 30810990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.